Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion type Assertion NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_head.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion description "[Extremely high insulin concentrations (860 nM) and 10 nM trIGF-I, a truncated form of IGF-I with the same affinity for the IGF-I receptor as the full-length IGF-I, but with lower activity on the insulin receptor, also upregulated UCP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_provenance.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion evidence source_evidence_literature NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_provenance.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion SIO_000772 11587536 NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_provenance.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion wasDerivedFrom befree-20140225 NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_provenance.
- NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_assertion wasGeneratedBy ECO_0000203 NP638299.RAbjZq4ifSCNdYx3vxeVxEm19VQpJe3D9FZZazE2Kh-sg130_provenance.